Sep 30, 2025 NB Health Laboratory and FRONTEO Signed PoC (Proof of Concept) Research Agreements Combining AI-Driven Drug Discovery with Antibody Drug Discovery Platform to Create Novel Antibody Drug Pipelines Targeting GPCRs
Aug 25, 2025 FRONTEO Presents Research on Exploring the Mechanism of Action of a Kampo Medicine Using the “Drug Discovery AI Factory” Building gene networks of Hochuekkito with proprietary natural language processing technology to explore scientific mechanisms
Aug 17, 2025 FRONTEO Signs Phase 2 Agreement with Daiichi Sankyo on Toxicity Information Analysis Using the Drug Discovery AI Factory Collaboration expands following validation of the “Text Analysis of Toxicology Study Reports” initiative
Aug 4, 2025 FRONTEO and NICCA Chemical Launch Co-Creation Project Utilizing the Drug Discovery AI Factory for Novel Target Discovery in the Cosmetics Field FRONTEO and NICCA Chemical Launch Co-Creation Project Utilizing the Drug Discovery AI Factory for Novel Target Discovery in the Cosmetics Field
Jul 22, 2025 FRONTEO Confirms the Cell Proliferation - Inhibitory Effect of Novel Pancreatic Cancer Target Candidates, Identified by its AI Drug Discovery Support Service "Drug Discovery AI Factory" Successfully uncovered numerous highly novel target molecule candidates in just two days, making a major advance in “target discovery”
Jul 22, 2025 FRONTEO and the University of Oklahoma begin Joint Research into Drug Discovery in the Oncology Field Analysis results from FRONTEO's "Drug Discovery AI Factory" will be verified at the University of Oklahoma, aiming to develop drugs that meet unmet medical needs.
Jul 8, 2025 Fuji Pharma and FRONTEO Launch Co-Creation Project to Evaluate Drug Discovery Seeds in the Women's Healthcare Field Accelerating Pharmaceutical R&D with the AI-Based Drug Discovery Support Service "Drug Discovery AI Factory"
Jun 29, 2025 Metagen Therapeutics and FRONTEO Launch Joint Research on Globally Watched Microbiome Drug Discovery Analyzing the Actions and Disease Associations of Gut Microbiota Using the Drug Discovery AI Factory
Jun 24, 2025 FRONTEO Accelerates U.S. Expansion — Signs Strategic Partnership Agreement with U.S.-based Q Partners, a Firm with Strengths in Life Sciences and Technology
May 14, 2025 FRONTEO and Chugai Pharmaceutical launch co-creation project for target discovery utilizing Drug Discovery AI Factory Accelerating R&D to Achieve First-in-Class and Best-in-Class Products Through Proprietary Technology That Systematically Discovers Unknown Disease–Molecule Correlations from Known Literature information.
May 12, 2025 FRONTEO and Institute of Science Tokyo Launch Joint Research on New Drug Discovery Targets Using the Drug Discovery AI Factory Verifying AI-Detected Drug Targets Through Both Dry and Wet Research to Develop Medicines Addressing Unmet Medical Needs
May 11, 2025 EA Pharma and FRONTEO Launch Co-Creation Project for AI-Powered Target Discovery in Drug Development